mHealth and Home Monitoring - 12th Edition

77 Million Patients Worldwide are Remotely Monitored

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring?

The number of connected home medical monitoring devices on the global market was 76.7 million at the end of 2023 and is forecasted to grow at a CAGR of 12.8% in the next five years to reach 140.1 million in 2028. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 320-page in-depth report now in its twelfth edition.

mHealth refers to the application of telecommunications in medicine and includes everything from connected medical devices to digital care programs. The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, sleep apnoea and diabetes. Other applications include remote diagnostics, compliance monitoring and clinical trials.

The revenues for remote patient monitoring (RPM) solutions reached 40.4 billion in 2023, including revenues from medical monitoring devices and mHealth software and services. RPM revenues are expected to grow at a CAGR of 13.9% between 2023 and 2028 to reach 77.3 billion at the end of the forecast period. Connected medical devices accounted for 54% of total RPM revenues in 2023. However, revenues for mHealth software and services are growing at a faster rate and will account for 58% of total revenues in 2028, up from 46% in 2023.

This report will allow you to:

Learn about key home health monitoring devices and services.
Study the strategies of 145 key players in the mHealth ecosystem.
Understand the dynamics of the health monitoring market in Europe and North America.
Comprehend how wireless technology can become seamlessly integrated with medical devices.
Evaluate the business opportunities in the emerging mHealth segment.
Predict future market and technology developments.

The report answers the following questions:

Which medical conditions offer the best potential for wireless health monitoring solutions?
Who are the leading providers of connected medical devices?
What are the mHealth strategies of medical device vendors and pharmaceutical companies?
What initiatives have been taken by the leading players in the telecom and IT industries?
How can connectivity redefine the use cases of medical devices and the value to patients?
Which are the general technology trends for home health monitoring equipment?
How are new reimbursement policies affecting the mHealth and connected care market?
How can healthcare providers and payers benefit from mHealth solutions?

Who should read this report?

mHealth and Home Monitoring is the foremost source of information about the adoption of wireless solutions for health monitoring. Whether you are a medical equipment vendor, telecom operator, healthcare provider, investor, consultant, or government agency, you will gain valuable insights from this in-depth research.

Executive Summary

1 The Challenge of Chronic Diseases

1.1 Introduction
1.1.1 The ageing population
1.1.2 Lifestyle-related diseases
1.2 Common chronic diseases
1.2.1 Cardiac arrhythmia
1.2.2 Chronic respiratory diseases
1.2.3 Congestive Heart Failure (CHF)
1.2.4 Diabetes
1.2.5 Hyperlipidaemia
1.2.6 Hypertension
1.2.7 Ischemic diseases
1.2.8 Sleep apnoea
1.3 Healthcare providers and reimbursement systems
1.3.1 Healthcare in Asia-Pacific
1.3.2 Healthcare in Europe
1.3.3 Healthcare in North America
1.4 Regulatory environment
1.4.1 Regulatory environment in Europe
1.4.2 Regulatory environment in North America
1.4.3 Regulatory environment in other major markets
1.4.4 International standardisation

2 mHealth Platforms

2.1 Overview of the mHealth market
2.1.1 mHealth market segments
2.1.2 Connectivity options for medical devices
2.1.3 The mHealth technology value chain
2.2 mHealth connectivity solutions
2.2.1 Alphabet
2.2.2 Apple
2.2.3 Bittium
2.2.4 Deutsche Telekom
2.2.5 eDevice
2.2.6 Enovacom (Orange)
2.2.7 KORE
2.2.8 MedM
2.2.9 Microsoft
2.2.10 PTC
2.2.11 Telenor
2.2.12 Vodafone
2.3 mHealth care delivery platforms
2.3.1 AT&T
2.3.2 Alira Health (Bepatient)
2.3.3 Aptar Digital Health
2.3.4 Clario
2.3.5 Doccla (OpenTeleHealth)
2.3.6 Domicalis
2.3.7 Enovation (Legrand Care)
2.3.8 Hope Care
2.3.9 Huma Therapeutics
2.3.10 Luscii (Omron Healthcare)
2.3.11 Medisanté
2.3.12 Medixine
2.3.13 S3 Connected Health
2.3.14 Sony Network Communications
2.3.15 TruBridge

3 Physiological Monitoring Solution Providers

3.1 Medical devices and remote monitoring
3.1.1 Medical device revenues by market segment
3.1.2 Overview of the remote patient monitoring market
3.2 Cardiac rhythm management
3.2.1 Overview of the CRM device market
3.2.2 Use cases for CRM monitoring
3.2.3 Remote monitoring solution providers
3.2.4 Abbott (St. Jude Medical)
3.2.5 BIOTRONIK
3.2.6 Boston Scientific
3.2.7 Medtronic
3.2.8 MicroPort Scientific
3.3 Remote ECG monitoring
3.3.1 Overview of the remote ECG monitoring device market
3.3.2 Use cases for remote ECG monitoring
3.3.3 Remote monitoring solution providers
3.3.4 AliveCor
3.3.5 Boston Scientific Cardiac Diagnostics (Preventice Solutions)
3.3.6 BioTelemetry (Philips ECG Solutions)
3.3.7 Biotricity
3.3.8 CardioComm Solutions
3.3.9 GE HealthCare
3.3.10 InfoBionic.Ai
3.3.11 iRhythm Technologies
3.3.12 LevMed
3.3.13 ScottCare Cardiovascular Solutions
3.3.14 TZ Medical
3.3.15 VitalConnect
3.3.16 Vivalink
3.3.17 Zenicor Medical Systems
3.4 Blood pressure monitoring
3.4.1 Overview of the blood pressure monitoring device market
3.4.2 Use cases for blood pressure monitoring
3.4.3 Remote monitoring solution providers
3.4.4 A&D Holon Holdings Company
3.4.5 iHealth Labs
3.4.6 Microlife
3.4.7 Omron Healthcare
3.4.8 Smart Meter
3.4.9 Rossmax
3.4.10 Welch-Allyn (Baxter International)
3.4.11 Withings
3.5 Coagulation monitoring
3.5.1 Overview of the coagulation monitoring device market
3.5.2 Use cases for blood coagulation monitoring
3.5.3 Remote monitoring solution providers
3.5.4 CoaguSense
3.5.5 Helena Laboratories
3.5.6 iLine Microsystems
3.5.7 Roche Diagnostics
3.5.8 Siemens Healthineers
3.5.9 Werfen (Instrumentation Laboratory)
3.6 Sleep therapy monitoring
3.6.1 Overview of the sleep therapy device market
3.6.2 Use cases for sleep therapy monitoring
3.6.3 Remote monitoring solution providers
3.6.4 BMC Medical
3.6.5 Fisher & Paykel Healthcare
3.6.6 Löwenstein Medical Technology
3.6.7 Philips Sleep and Respiratory Care
3.6.8 ResMed
3.6.9 SRETT
3.6.10 Somnics Health
3.6.11 SomnoMed
3.7 Home sleep diagnostics
3.7.1 Overview of the home sleep diagnostics market
3.7.2 Use cases for home sleep diagnostics
3.7.3 Remote monitoring solution providers
3.7.4 Acurable
3.7.5 BioSerenity
3.7.6 Cadwell Laboratories
3.7.7 CleveMed
3.7.8 Compumedics
3.7.9 Natus Medical
3.7.10 Nox Medical
3.7.11 Onera Health
3.7.12 SOMNOmedics
3.7.13 Wesper
3.7.14 Zoll Itamar
3.8 Blood oxygen monitoring
3.8.1 Overview of the blood oxygen monitoring device market
3.8.2 Use cases for blood oxygen monitoring
3.8.3 Remote monitoring solution providers
3.8.4 BodiMetrics
3.8.5 ChoiceMMed
3.8.6 Masimo
3.8.7 Nonin Medical
3.9 Airflow monitoring
3.9.1 Overview of the air flow monitoring device market
3.9.2 Use cases for airflow monitoring
3.9.3 Remote monitoring solution providers
3.9.4 AstraZeneca
3.9.5 Adherium
3.9.6 Medical International Research
3.9.7 Monitored Therapeutics
3.9.8 NDD Medical Technologies
3.9.9 NIOX Group (Circassia Group)
3.9.10 Propeller Health
3.9.11 Respiri
3.9.12 Sibelmed
3.9.13 Smart Respiratory
3.9.14 Vitalograph
3.10 Glucose level monitoring
3.10.1 Overview of the glucose monitoring device market
3.10.2 Use cases for glucose monitoring
3.10.3 Remote monitoring solution providers
3.10.4 Abbott Diabetes Care
3.10.5 Ascensia Diabetes Care
3.10.6 BioTel Care (Philips)
3.10.7 Dexcom
3.10.8 Glooko
3.10.9 Insulet
3.10.10 LifeScan
3.10.11 Medtronic Diabetes Operating Unit
3.10.12 Roche Diabetes Care
3.10.13 Senseonics
3.10.14 Tandem Diabetes Care
3.10.15 Welldoc
3.11 Other
3.11.1 Implantable medical devices
3.11.2 Home haemodialysis
3.11.3 Thermometers and weight scales
3.11.4 Mental health
3.11.5 Cholesterol monitoring

4 Medication, AED and Integrated Monitoring Solution Providers

4.1 Telehealth and multiparameter monitoring solutions
4.1.1 Overview of the telehealth solutions market
4.1.2 Use cases for telehealth solutions
4.1.3 Telehealth solution providers
4.1.4 Accuhealth
4.1.5 AMC Health
4.1.6 American Well (Amwell)
4.1.7 Biofourmis
4.1.8 CareSimple
4.1.9 Current Health (BestBuy Health)
4.1.10 Medtronic Care Management Services
4.1.11 Philips Enterprise Telehealth
4.1.12 SHL Telemedicine
4.1.13 Teladoc Health
4.1.14 Telefónica
4.1.15 TytoCare
4.2 Medication compliance monitoring
4.2.1 Overview of the medication compliance monitoring market
4.2.2 Use cases for medication compliance monitoring
4.2.3 Compliance monitoring solution providers
4.2.4 AceAge
4.2.5 AdhereTech
4.2.6 Compliance Meds Technologies
4.2.7 etectRx
4.2.8 Evondos
4.2.9 Hero
4.2.10 Information Mediary Corporation
4.2.11 iZafe Group
4.2.12 Medimi
4.2.13 MedMinder
4.2.14 MedReady
4.2.15 Merck Group
4.2.16 Mevia
4.2.17 RGF Diagnostics (Mymemo)
4.2.18 Spencer Health Solutions
4.2.19 Vaica
4.3 Connected automated external defibrillators
4.3.1 Overview of the connected defibrillator market
4.3.2 Use cases for automated external defibrillators
4.3.3 Connected solution providers
4.3.4 Almas Industries
4.3.5 Avive Solutions
4.3.6 Cardia International
4.3.7 CardiLink
4.3.8 Metrax
4.3.9 Nihon Kohden
4.3.10 Philips Emergency Care
4.3.11 Physio-Control (Stryker)
4.3.12 PYRESCOM
4.3.13 Schiller
4.3.14 Zoll Medical (Asahi Kasei)

5 Market Analysis and Forecasts

5.1 Market forecasts
5.1.1 Cardiac rhythm management
5.1.2 Sleep therapy
5.1.3 Telehealth and multiparameter monitoring
5.1.4 ECG monitoring
5.1.5 Glucose level monitoring
5.1.6 Medication compliance monitoring
5.1.7 Other medical devices
5.2 Revenue forecasts
5.2.1 Medical monitoring devices
5.2.2 mHealth software and services
5.3 Market drivers and barriers
5.3.1 An ageing population increases the demand for care services
5.3.2 Increase of non-communicable disease prevalence
5.3.3 The generational technology barrier is disappearing
5.3.4 Healthcare staff shortages calls for more efficient healthcare
5.3.5 Increasing government reimbursement for mHealth applications
5.3.6 Transformation to value-based care
5.3.7 Increased focus on disease prevention
5.3.8 Substitutes to medical monitoring
5.3.9 A slowly changing industry
5.3.10 Critical role of cybersecurity in digital solutions
5.3.11 Increased need for interoperability as the number of solutions grows
5.4 Industry trends and analysis
5.4.1 The role of AI and machine learning in transforming mHealth
5.4.2 Integrations are becoming crucial in the health data ecosystem
5.4.3 Consumerisation of medical-grade mHealth devices and apps
5.4.4 How cellular technologies enable reliable connectivity for medical devices
5.4.5 Major pharmaceutical companies prepare large-scale rollouts
5.4.6 BYOD is becoming a popular and viable option
5.4.7 The global adoption of telehealth is ramping up
5.4.8 Compliance monitoring is a major driver behind home monitoring
5.4.9 COVID-19 became a catalyst that took mHealth into the next growth phase

List of Acronyms and Abbreviations

List of Figures

Figure 1.1: Population estimates and share older than 65 years (1960-2050)
Figure 1.2: Number of people suffering from chronic diseases (EU/US 2020-2023)
Figure 1.3: Prevalence of diabetes by region (World 2021-2045)
Figure 1.4: Share of the population covered by private health insurance (2022)
Figure 1.5: Total health expenditure per capita by country (2022)
Figure 1.6: Health insurance coverage by type of insurance (US 2022)
Figure 1.7: Total and per capita healthcare expenditure by country (North America 2022)
Figure 1.8: Healthcare spending by type of service and product (Canada 2023)
Figure 2.1: mHealth market segments
Figure 2.2: Connected medical devices and the provision of care
Figure 2.3: Overview of the mHealth technology value chain
Figure 2.4: The main focus areas of mHealth connectivity solution providers
Figure 2.5: Examples of apps that can be connected to Google Fit
Figure 2.6: Examples of apps available on App Store by focus area
Figure 2.7: HealthGO by eDevice
Figure 2.8: MedM RPM Platform, mobile apps and caregiver portal
Figure 2.9: The Health Storylines app
Figure 2.10: Medixine Suite
Figure 2.11: mSafety as a platform
Figure 3.1: Medical device market revenues by segment (World 2022-2028)
Figure 3.2: Connected medical devices by segment (World 2023)
Figure 3.3: Implantable cardiac rhythm management vendor market shares (2023)
Figure 3.4: Examples of implantable CRM devices
Figure 3.5: The Medtronic MyCareLink patient monitor
Figure 3.6: Market shares for remote monitoring of CRM implants (2023)
Figure 3.7: The Merlin.net interface, Merlin@home transmitter and the myMerlinPulse app ..
Figure 3.8: BIOTRONIK’s home monitoring service center data transmission
Figure 3.9: Latitude NXT Wave wireless communicator
Figure 3.10: MCT sensor and monitor from Philips
Figure 3.11: Implantable Cardiac Monitors from Medtronic
Figure 3.12: AliveCor’s products and Kardia App
Figure 3.13: HeartCheck devices from CardioComm Solutions
Figure 3.14: Examples of blood pressure monitors
Figure 3.15: A&D connected products and Heart Track app
Figure 3.16: Omron Healthcare’s connected product family
Figure 3.17: The VitalSight kit for remote patient monitoring by Omron Healthcare
Figure 3.18: Withings connected devices, data hub and RPM solution
Figure 3.19: The Coag-Sense PT2 Meter
Figure 3.20: Sleep therapy vendor market shares (2023)
Figure 3.21: ResMed AirSense 11 CPAP device and myAir app
Figure 3.22: Connected sleep therapy solutions by vendor (2023)
Figure 3.23: Philips DreamMapper mobile application
Figure 3.24: ResMed myAir with the Care Check-In and Personal Therapy Assistant
Figure 3.25: SomnoDent Classic
Figure 3.26: Zoll Itamar’s connected home sleep monitoring device
Figure 3.27: Examples of home sleep diagnostics companies and products
Figure 3.28: CleveMed SleepView Monitor
Figure 3.29: Home sleep testing devices from Compumedics
Figure 3.30: The Nox A1 Device Source: Nox Medical
Figure 3.31: iSpO2 (left) and MightySat device and application (right)
Figure 3.32: Masimo SafetyNet workflow
Figure 3.33: The Hailie platform
Figure 3.34: GoSpiro spirometer device
Figure 3.35: Propeller Health’s asthma management app and inhaler sensor
Figure 3.36: Respiri’s device and app
Figure 3.37: Blood glucose meter vendor market shares (2023)
Figure 3.38: CGM and insulin delivery system vendor market shares (2023)
Figure 3.39: Glucose meters from Livongo and Roche
Figure 3.40: Dexcom CGM system
Figure 3.41: Medtronic’s MiniMed 780G integrated insulin delivery system
Figure 3.42: Examples of connected blood glucose meters
Figure 3.43: Examples of connected CGM and insulin pump systems
Figure 3.44: FreeStyle Libre 3 CGM system
Figure 3.45: Dexcom G7 family
Figure 3.46: The Glooko Transmitter
Figure 3.47: Insulet Omnipod 5
Figure 3.48: Roche mySugr app
Figure 3.49: Accu-Chek SmartGuide CGM solution
Figure 3.50: Tandem Mobi insulin pump system
Figure 3.51: Welldoc BlueStar
Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape
Figure 4.2: Installed base of telehealth hubs by region (2023)
Figure 4.3: eCareCompanion and eCareCoordinator from Philips
Figure 4.4: Compliance monitoring solution form factors
Figure 4.5: Connected medication compliance solutions by vendor (2023)
Figure 4.6: The AdhereTech smart pill bottle
Figure 4.7: The CleverCap Pro dispenser
Figure 4.8: The Evondos E300 automatic medicine dispenser and Medido dispenser
Figure 4.9: Hero pill dispenser and Hero mobile app
Figure 4.10: Dosell medication dispenser
Figure 4.11: The MedMinder pill dispenser
Figure 4.12: The Easypod injector and the Easypod transmitter
Figure 4.13: Medose and Mepill from Mevia
Figure 4.14: Mymemo automatic pill dispenser
Figure 4.15: The Spencer SmartHub from Spencer Health Solutions
Figure 4.16: AED registries
Figure 4.17: The DOC defibrillator from Almas Industries
Figure 4.18: CardiLink application interface
Figure 5.1: Connected home medical monitoring devices (World 2022-2028)
Figure 5.2: Connected home medical monitoring devices by region (World 2022-2028)
Figure 5.3: Connected cardiac rhythm management devices (World 2022-2028)
Figure 5.4: Connected sleep therapy devices (World 2022-2028)
Figure 5.5: Telehealth hubs (World 2022-2028)
Figure 5.6: Connected ECG monitoring devices (World 2022-2028)
Figure 5.7: Connected glucose monitoring devices (World 2022-2028)
Figure 5.8: Connected medication monitoring solutions (World 2022-2028)
Figure 5.9: Other connected medical devices (World 2022-2028)
Figure 5.10: Remote patient monitoring revenues (World 2022-2028)
Figure 5.11: Connected medical device revenues (World 2023-2028)
Figure 5.12: mHealth software and services revenues (World 2022-2028)
Figure 5.13: Elderly population (65+) as a percentage of total population (2023)
Figure 5.14: Summary of CPT codes

Executive Summary

The number of remotely monitored patients reached 76.7 million in 2023, reflecting growing market acceptance. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. The report estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 12.8 percent to reach 140.1 million by 2028. Cellular connectivity remains the defacto standard communications technology for most types of connected home medical monitoring devices and will account for 68.7 million connections in 2028. However, the trend of using patients’ own mobile devices as health hubs is gaining traction. By 2028, a total of 67.9 million patients will rely on BYOD connectivity.

The report estimates that revenues for remote patient monitoring (RPM) solutions reached € 40.4 billion in 2023, including revenues from medical monitoring devices and mHealth software and services. RPM revenues are expected to grow at a CAGR of 13.9 percent between 2023 and 2028 to reach € 77.3 billion at the end of the forecast period.

Connected medical devices accounted for 54 percent of total RPM revenues in 2023. However, revenues for mHealth software and services are growing at a faster rate and will account for 58 percent of total revenues in 2028, up from 46 percent in 2023.

There is a strong trend towards incorporating more connectivity in medical devices in order to enable new services and value propositions. Sleep therapy is by far the most connected segment and is dominated by ResMed. The number of monitored patients continues to grow and has more than doubled since 2018, largely due to the compliance monitoring requirements that have been introduced in the US and Europe. Implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies such as Medtronic, Abbott, Boston Scientific and BIOTRONIK that included connectivity in CRM solutions two decades ago. The report anticipates that the fastest growing market segments in the next five years are likely to be remote ECG monitoring, glucose monitoring and medication compliance monitoring. Today, the leading connected healthcare players in these segments include forwardthinking incumbents as well as innovative new entrants such as AliveCor, Abbott, Boston Scientific, Compliance 77 million patients worldwide are remotely monitored

Meds Technologies, Evondos, Phillips, Dexcom, Glooko, Hero, Insulet, iRhythm Technologies, InfoBionic, MedMinder, MedReady, Medtronic, Tandem Diabetes Care and WellDoc. mHealth software and services are one of the most rapidly developing parts of the mHealth value chain. This segment includes platforms for remote patient monitoring, which utilize connected devices like wearables and sensors to track vital signs and health metrics in real-time. Service providers in this space offer comprehensive solutions that integrate data analytics, telehealth capabilities and patient engagement tools to ensure continuous and efficient care. Companies that specialise in this area include Accuhealth, Aptar Digital Health, Alira Health (Bepatient), Biofourmis, Huma Therapeutics, Omron Healthcare (Luscii), S3 Connected
Health, Teladoc Health (Livongo), Enovation and Welldoc.

The global healthcare sector is undergoing a technological transformation driven by evolving patient needs and the lasting impact of the COVID-19 pandemic. This has led to the steady integration of remote patient monitoring technologies, with telehealth and remote monitoring becoming the new standard for care delivery. Providers are incorporating social care models into public health systems to better address patient needs. Medical providers and technology companies are seeking ways to revolutionize care by streamlining costs, reducing hospital readmission rates and expanding access to care in remote areas. Key trends include the entry of new companies into the connected healthcare market, the growing importance of digital health data for designing patient management solutions and the rapid adoption of telehealth and compliance monitoring. In recent years, the healthcare industry has seen a shift towards mHealth technologies, from fitness tracking apps to platforms integrating augmented reality and wearable tech. Artificial intelligence has advanced significantly, aiding in disease detection and personalized treatment by analysing large datasets. This shift supports the move from data collection to proactive and personalized solutions. Additionally, using patients’ own mobile devices as health hubs has become a viable alternative. The report predicts that this transformation will drive strong growth in the mHealth industry over the next five years.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott (St. Jude Medical)
Abbott Diabetes Care
Accuhealth
AceAge
Adherium
AdhereTech
AliveCor
Alira Health (Bepatient)
Alphabet
Almas Industries
AMC Health
American Well (Amwell)
Aptar Digital Health
Apple
Ascensia Diabetes Care
AstraZeneca
AT&T
Avive Solutions
BIOTRONIK
Biofourmis
BioSerenity
BioTel Care (Philips)
BioTelemetry (Philips ECG Solutions)
Biotricity
Bittium
BMC Medical
BodiMetrics
Boston Scientific
Boston Scientific Cardiac Diagnostics (Preventice Solutions)
Cadwell Laboratories
Cardia International
CardiLink
CardioComm Solutions
CareSimple
Clario
CleveMed
CoaguSense
Compliance Meds Technologies
Compumedics
Current Health (BestBuy Health)
Deutsche Telekom
Dexcom
Doccla (OpenTeleHealth)
Domicalis
eDevice
Enovacom (Orange)
Enovation (Legrand Care)
etectRx
Evondos
Fisher & Paykel Healthcare
GE HealthCare
Glooko
Helena Laboratories
Hero
Hope Care
Huma Therapeutics
iHealth Labs
iLine Microsystems
Information Mediary Corporation
Insulet
iRhythm Technologies
iZafe Group
KORE
LevMed
LifeScan
Löwenstein Medical Technology
Luscii (Omron Healthcare)
Masimo
Medical International Research
Medimi
Medisanté
Medixine
MedM
MedMinder
MedReady
Medtronic
Medtronic Care Management Services
Medtronic Diabetes Operating Unit
Merck Group
Mevia
Microsoft
Microlife
MicroPort Scientific
Monitored Therapeutics
Natus Medical
NDD Medical Technologies
Nihon Kohden
NIOX Group (Circassia Group)
Nonin Medical
Nox Medical
Onera Health
Omron Healthcare
Philips Emergency Care
Philips Enterprise Telehealth
Philips Sleep and Respiratory Care
Physio-Control (Stryker)
Propeller Health
PTC
PYRESCOM
ResMed
Respiri
RGF Diagnostics (Mymemo)
Roche Diabetes Care
Roche Diagnostics
Rossmax
S3 Connected Health
Schiller
ScottCare Cardiovascular Solutions
Senseonics
SHL Telemedicine
Siemens Healthineers
Sibelmed
Smart Meter
Smart Respiratory
SOMNOmedics
Somnics Health
SomnoMed
Sony Network Communications
Spencer Health Solutions
SRETT
Teladoc Health
Telefónica
Telenor
TruBridge
TZ Medical
TytoCare
Vaica
VitalConnect
Vitalograph
Vivalink
Vodafone
Welch-Allyn (Baxter International)
Welldoc
Werfen (Instrumentation Laboratory)
Wesper
Withings
Zenicor Medical Systems
Zoll Itamar
Zoll Medical (Asahi Kasei)

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	320
Published	September 2024
Forecast Period	2023 - 2028
Estimated Market Value ( USD ) in 2023	$ 76.7 Million
Forecasted Market Value ( USD ) by 2028	$ 140.1 Million
Compound Annual Growth Rate	12.8%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€1800EUR$2,040USD£1,561GBP
1 - 10 USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a 1-10 user license, allowing up to ten users have access to the product.	€2700EUR$3,060USD£2,341GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€3600EUR$4,079USD£3,121GBP

This report will allow you to:

The report answers the following questions:

Who should read this report?

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

mHealth Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

Global mHealth Market by Product (Connected Medical Devices, Mobile Health Apps, Mobile Health Services), End User (Healthcare Patients, Healthcare Payers, Healthcare Providers), Application - Forecast 2024-2030

mHealth Market Size, Share & Trends Analysis Report By Component (Wearables & Connected Wearable Devices, mHealth Apps, Services), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Global Mhealth Market by Component, by End-user, and by Region

mHealth Apps Global Market Report 2024